Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

UPCOMING FEATURED EVENTS 1 2 Next 
Neuroscience 201415 Nov 2014 Read
ASCB 20146 Dec 2014 Read
SLAS20157 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read
ESCMID European Society of Clinical Microbiology and Infectious Diseases25 Apr 2015 Read
AACC (American Association for Clinical Chemistry)26 Jul 2015 Read
Neuroscience 201517 Oct 2015 Read


ALL UPCOMING EVENTS
1 2 3 Next 
AACC (American Association for Clinical Chemistry)26 Jul 2015 Read
Microscopy & Microanalysis2 Aug 2015 Read
WMIC 20152 Sep 2015 Read
ASHG 20156 Oct 2015 Read
Neuroscience 201517 Oct 2015 Read
AAPS 201525 Oct 2015 Read
Medica 201516 Nov 2015 Read
ASCB 201512 Dec 2015 Read